Omolola Salako, MBBS, FWACS, Founder and CEO, Oncopadi Technologies speaks about the Astellas Oncology C3 Prize – This Years Grand Prize Winner.
The Astellas Oncology C3 Prize, launched in 2016, is a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine. The C3 Prize sparks innovative developments in cancer care, tackling cancer challenges by awarding the winners with grants and connecting them with resources and support.
Link to Astellas C3 Prize:
http://www.c3prize.com/
Link To Oncopadi:
https://oncopadi.com/
Link to the Apple App Store:
https://apps.apple.com/kw/app/oncopadi/id1534418355
Link to Google Play:
https://play.google.com/store/apps/details?id=com.oncopadi.org
Idea:
An app that connects cancer patients with the specialists and hospitals they need to access care.
Oncopadi is based on using technology to democratize cancer awareness and care so that people can discover whether they have cancer and receive treatment before it progresses. Oncopadi is a digital patient navigator that offers telemedicine, a symptom tracker, patient informational resources, and a supportive online cancer support community.
Omolola Salako is a cancer treatment innovator who strives to solve complicated problems. Her personal journey to improve cancer treatment began in 2003 when her sister was diagnosed with advanced kidney cancer and died within three months of being diagnosed. Her interest was ignited by the experience, and she went on to pursue a career as a result of it. She is now concentrating on creating a healthy environment for cancer patients. Anyone diagnosed with cancer, according to Omolola, should have immediate access to reliable cancer information and support.